Madhukar H. Trivedi, MD

  • 112Articles
  • 487.3KReads
  • 1998–2025Active
  • 357Collaborators
  • 4.9KCitations

About

Madhukar H. Trivedi, MD, is affiliated with the University of Texas Southwestern Medical Center in Dallas, Texas. With a publication record spanning from 1998 to 2025, Trivedi has contributed extensively to topics including depression, psychiatry, suicide, addiction, child and adolescent psychiatry, anxiety, pain, and patient care. Frequent collaborators include A. John Rush, Maurizio Fava, Michael E. Thase, George I. Papakostas, and Richard C. Shelton.

Publications

JCP
Original Research

Adjunctive Pimavanserin and Sleep/Wakefulness in MDD

December 1, 2020

Adjunctive pimavanserin can reduce depressive symptoms and improve function in patients with major depression and inadequate antidepressant response. This analysis evaluated the effects of adjunctive pimavanserin on sleep/wakefulness disturbances.
, , , et al
JCP
Original Research

Switching Antidepressants Following SSRI Failure

August 11, 2020

An antidepressant medication switch often follows a failed initial trial with SSRIs. This study sought to determine the probability and timing of both response and remission and the optimal...
, , , et al
JCP
Commentary

MDD Treatment: Response to Antidepressants

May 19, 2020

Read commentary on inadequate antidepressant response for MDD. Determining where patients are on the response continuum and managing inadequate response.
, , , et al
JCP
Overcoming Challenges to Treat Inadequate Response in MDD
Educational Activity

Overcoming Challenges to Treat Inadequate Response in MDD

May 12, 2020

How do you determine if a patient is experiencing nonresponse to an antidepressant? In this activity, experts discuss augmentation and adjunctive treatment strategies, as well as best practices for...
, , , et al
JCP
Augmentation and Adjunctive Strategies for Inadequate Response in MDD
Educational Activity

Augmentation and Adjunctive Strategies for Inadequate Response in MDD

May 12, 2020

When a patient with major depressive disorder isn't responding to antidepressant treatment, what are your next moves? In this activity, learn from the experts about augmentation and adjunctive strategies.
, , , et al
JCP
Recognizing Inadequate Response in Patients With MDD
Educational Activity

Recognizing Inadequate Response in Patients With MDD

May 5, 2020

Can you recognize inadequate antidepressant response? How does it differ from treatment-resistant depression? In this activity, experts discuss definitions of response as well as residual symptoms seen with inadequate...
, , , et al
JCP
Use of Measurement-Based Care to Address Inadequate Antidepressant Response
Educational Activity

Use of Measurement-Based Care to Address Inadequate Antidepressant Response

May 5, 2020

You may think using rating scales to measure depression symptoms takes too long. But that time may be well spent. In this activity, experts discuss the value of measurement-based...
, , , et al
JCP
Educational Activity

Treating MDD in Primary Care

March 17, 2020

When you are treating a patient for depression, do you regularly assess symptoms, adherence, and side effects using tools and then use that information to guide treatment decisions? Learn...
JCP
Educational Activity

Identifying MDD in Primary Care

March 17, 2020

Identification of depression is crucial, as untreated depression is linked to functional impairment and suicide. Learn from an expert about how measurement-based care provides a way to improve the...
JCP
Original Research

Adjunctive Pimavanserin in Treatment-Resistant MDD

September 24, 2019

The use of atypical antipsychotics as adjunctive treatment for nonresponsive depression is limited by their side effects. This study explores whether pimavanserin can be both an efficacious and tolerable...
, , , et al
JCP
Original Research

CAST-SR Psychometrics in Stimulant Use Disorder

January 9, 2018

The self-report Concise Associated Symptoms Tracking Scale (CAST-SR) was designed to track symptoms such as mania and anxiety in depressed outpatients being treated with antidepressants. This study used data...
, , , et al
JCP
Academic Highlights

Utilizing the DSM-5 Anxious Distress Specifier to Develop Treatment Strategies for Patients With Major Depressive Disorder

November 28, 2017

Many of your patients with depression also experience anxiety symptoms, and addressing these symptoms is a crucial part of successful treatment. Explore this free Academic Highlights activity to learn...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe